Klotho Cash from 2010 to 2026
| KLTO Stock | 0.24 0.02 9.09% |
Cash | First Reported 2010-12-31 | Previous Quarter 57.4 K | Current Value 54.5 K | Quarterly Volatility 133.1 K |
Check Klotho Neurosciences financial statements over time to gain insight into future company performance. You can evaluate financial statements to find patterns among Klotho Neurosciences' main balance sheet or income statement drivers, such as Depreciation And Amortization of 730.5 K, Selling General Administrative of 6.7 M or Selling And Marketing Expenses of 598, as well as many indicators such as Price To Sales Ratio of 0.0, Dividend Yield of 0.0 or PTB Ratio of 8.6. Klotho financial statements analysis is a perfect complement when working with Klotho Neurosciences Valuation or Volatility modules.
Klotho | Cash | Build AI portfolio with Klotho Stock |
Evaluating Klotho Neurosciences's Cash across multiple reporting periods reveals the company's ability to sustain growth and manage resources effectively. This longitudinal analysis highlights inflection points, cyclical patterns, and structural changes that short-term snapshots might miss, offering deeper insight into Klotho Neurosciences's fundamental strength.
Latest Klotho Neurosciences' Cash Growth Pattern
Below is the plot of the Cash of Klotho Neurosciences over the last few years. Cash refers to the most liquid asset of Klotho Neurosciences, which is listed under current asset account on Klotho Neurosciences balance sheet and usually includes currency, coins, checking accounts, and not deposited checks received from Klotho Neurosciences customers. The amounts must be unrestricted with restricted cash listed in a different Klotho Neurosciences account. It is the total amount of money in the form of currency that a company has in its possession. This includes all bills, coins, and funds in bank accounts. Klotho Neurosciences' Cash historical data analysis aims to capture in quantitative terms the overall pattern of either growth or decline in Klotho Neurosciences' overall financial position and show how it may be relating to other accounts over time.
| Cash | 10 Years Trend |
|
Cash |
| Timeline |
Klotho Cash Regression Statistics
| Arithmetic Mean | 249,338 | |
| Geometric Mean | 169,136 | |
| Coefficient Of Variation | 53.36 | |
| Mean Deviation | 116,754 | |
| Median | 334,874 | |
| Standard Deviation | 133,056 | |
| Sample Variance | 17.7B | |
| Range | 332.1K | |
| R-Value | (0.80) | |
| Mean Square Error | 6.8B | |
| R-Squared | 0.64 | |
| Significance | 0.0001 | |
| Slope | (21,105) | |
| Total Sum of Squares | 283.3B |
Klotho Cash History
Other Fundumenentals of Klotho Neurosciences
| Cash And Short Term Investments | ||
| Change In Cash | ||
| Free Cash Flow | ||
| Other Cashflows From Financing Activities |
Klotho Neurosciences Cash component correlations
Click cells to compare fundamentals
About Klotho Neurosciences Financial Statements
Klotho Neurosciences investors utilize fundamental indicators, such as Cash, to predict how Klotho Stock might perform in the future. Analyzing these trends over time helps investors make informed market timing decisions. For further insights, please visit our fundamental analysis page.
| Last Reported | Projected for Next Year | ||
| Cash | 57.4 K | 54.5 K | |
| Cash And Short Term Investments | 57.4 K | 54.5 K | |
| Change In Cash | 54.8 K | 57.6 K | |
| Free Cash Flow | -2.8 M | -2.6 M | |
| Other Cashflows From Financing Activities | 895.8 K | 940.6 K | |
| Total Cash From Operating Activities | -2.7 M | -2.5 M | |
| Total Cash From Financing Activities | 3.6 M | 3.8 M | |
| End Period Cash Flow | 57.4 K | 54.5 K | |
| Begin Period Cash Flow | 2.5 K | 2.4 K | |
| Total Cashflows From Investing Activities | -142 K | -149.1 K | |
| Other Cashflows From Investing Activities | 34 K | 30.2 K | |
| Other Non Cash Items | 363.3 K | 323 K | |
| Free Cash Flow Yield | (0.38) | (0.36) | |
| Operating Cash Flow Per Share | (0.18) | (0.17) | |
| Free Cash Flow Per Share | (0.18) | (0.17) | |
| Capex To Operating Cash Flow | (0.04) | (0.04) | |
| EV To Operating Cash Flow | (2.91) | (3.06) | |
| EV To Free Cash Flow | (2.80) | (2.94) | |
| Price To Operating Cash Flows Ratio | (2.85) | (2.99) | |
| Price To Free Cash Flows Ratio | (2.74) | (2.87) | |
| Cash Ratio | 0.06 | 0.06 | |
| Free Cash Flow Operating Cash Flow Ratio | 1.04 | 1.20 | |
| Cash Flow Coverage Ratios | (12.47) | (11.85) | |
| Price Cash Flow Ratio | (2.85) | (2.99) | |
| Cash Flow To Debt Ratio | (12.47) | (11.85) |
Pair Trading with Klotho Neurosciences
One of the main advantages of trading using pair correlations is that every trade hedges away some risk. Because there are two separate transactions required, even if Klotho Neurosciences position performs unexpectedly, the other equity can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Klotho Neurosciences will appreciate offsetting losses from the drop in the long position's value.Moving together with Klotho Stock
Moving against Klotho Stock
| 0.85 | IMMP | Immutep Ltd ADR | PairCorr |
| 0.67 | DSGN | Design Therapeutics | PairCorr |
| 0.64 | ENGN | enGene Holdings Common | PairCorr |
| 0.53 | 63E | ONWARD MEDICAL BV | PairCorr |
| 0.52 | KYTX | Kyverna Therapeutics | PairCorr |
The ability to find closely correlated positions to Klotho Neurosciences could be a great tool in your tax-loss harvesting strategies, allowing investors a quick way to find a similar-enough asset to replace Klotho Neurosciences when you sell it. If you don't do this, your portfolio allocation will be skewed against your target asset allocation. So, investors can't just sell and buy back Klotho Neurosciences - that would be a violation of the tax code under the "wash sale" rule, and this is why you need to find a similar enough asset and use the proceeds from selling Klotho Neurosciences to buy it.
The correlation of Klotho Neurosciences is a statistical measure of how it moves in relation to other instruments. This measure is expressed in what is known as the correlation coefficient, which ranges between -1 and +1. A perfect positive correlation (i.e., a correlation coefficient of +1) implies that as Klotho Neurosciences moves, either up or down, the other security will move in the same direction. Alternatively, perfect negative correlation means that if Klotho Neurosciences moves in either direction, the perfectly negatively correlated security will move in the opposite direction. If the correlation is 0, the equities are not correlated; they are entirely random. A correlation greater than 0.8 is generally described as strong, whereas a correlation less than 0.5 is generally considered weak.
Correlation analysis and pair trading evaluation for Klotho Neurosciences can also be used as hedging techniques within a particular sector or industry or even over random equities to generate a better risk-adjusted return on your portfolios.Check out the analysis of Klotho Neurosciences Correlation against competitors. To learn how to invest in Klotho Stock, please use our How to Invest in Klotho Neurosciences guide.You can also try the Idea Breakdown module to analyze constituents of all Macroaxis ideas. Macroaxis investment ideas are predefined, sector-focused investing themes.
Will Biotechnology sector continue expanding? Could Klotho diversify its offerings? Factors like these will boost the valuation of Klotho Neurosciences. Expected growth trajectory for Klotho significantly influences the price investors are willing to assign. Accurate valuation requires analyzing both current fundamentals and future growth trajectories. Every Klotho Neurosciences data point contributes insight, yet successful analysis hinges on identifying the most consequential variables.
The market value of Klotho Neurosciences is measured differently than its book value, which is the value of Klotho that is recorded on the company's balance sheet. Investors also form their own opinion of Klotho Neurosciences' value that differs from its market value or its book value, called intrinsic value, which is Klotho Neurosciences' true underlying value. Seasoned market participants apply comprehensive analytical frameworks to derive fundamental worth and identify mispriced opportunities. Because Klotho Neurosciences' market value can be influenced by many factors that don't directly affect Klotho Neurosciences' underlying business (such as a pandemic or basic market pessimism), market value can vary widely from intrinsic value.
Understanding that Klotho Neurosciences' value differs from its trading price is crucial, as each reflects different aspects of the company. Evaluating whether Klotho Neurosciences represents a sound investment requires analyzing earnings trends, revenue growth, technical signals, industry dynamics, and expert forecasts. Meanwhile, Klotho Neurosciences' quoted price indicates the marketplace figure where supply meets demand through bilateral consent.